We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kyle Binder

Kyle Binder MD

Clinical Fellow, Neuroimmunology Clinic, National Institutes of Health, Bethesda, Maryland

Dr. Kyle Binder is a Clinical Fellow at the National Institutes of Health in Bethesda, Maryland, where he provides clinical care for the Neuroimmunology Clinic. Dr. Binder received his M.D. and Ph.D. in Molecular Genetics and Genomics from Wake Forest University in Winston-Salem, North Carolina.  His Ph.D. research in skin bioprinting was performed in conjunction with the Armed Forces Institutes for Regenerative Medicine to assist with burn repair for wounded soldiers.  He received several research awards for his work in this field.  During medical school he developed a passion for Neurology and completed his residency in the Neurology Residency Program at Wake Forest University, where he received the Resident Teaching Award and the Resident Research Award.

His current research is aimed at leveraging next generation genetic sequencing to identify the genetic basis of familial multiple sclerosis. He is also involved in determining the mechanism of tolerogen presentation in the inflamed central nervous system.


Dr. Binder reports no relevant disclosures.